← Leaderboards
Avrum E Spira
Boston University Medical Campus
$17,711,843
Attributed
$42,911,946
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.3M · FY2005–21$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$49,864,696 · 15
By mechanism
U01$14,837,285 · 4
R01$11,883,799 · 7
U2C$11,467,420 · 2
RC2$11,401,676 · 1
R21$274,516 · 1
Top collaborators
- Marc Elliott Lenburg26 shared
- Steven M. Dubinett18 shared
- David Elashoff10 shared
- Denise R Aberle8 shared
- Fenghai Duan5 shared
- Stephen C Lam4 shared
- Peter David Pare4 shared
- Don Sin4 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Marc Elliott Lenburg$9,912,830
- Andrew A Wilson$8,485,651
- Don Sin$523,708
- Kristine Abo$160,107
- Jennifer Ellen Beane$212,128
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMolecular ProfilingBaseMalignant Neoplasm Of LungLungSmokerGene ExpressionResearch PersonnelEpithelialGene Expression ProfilePathogenesisSamplingCohortInjuryStagingEpithelial CellsGenomicsProgramsPathway InteractionsAirway EpitheliumGeneticGenesBronchoscopyMessenger Rna
Grant awards (55)
Administrative Core$100,000
U2C · FY2021 · CA · contact PI
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy$100,000
U2C · FY2021 · CA · contact PI
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy$159,890
U2C · FY2020 · CA · contact PI
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy$6,692,860
U2C · FY2018 · CA · contact PI
Administrative Core$4,414,670
U2C · FY2018 · CA · contact PI
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$1,218,395
U01 · FY2018 · CA
The Boston University-UCLA Lung Cancer Biomarker Development Lab$860,456
U01 · FY2017 · CA · contact PI
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$764,788
U01 · FY2017 · CA
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$456,656
U01 · FY2017 · CA
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$2,239,851
U01 · FY2016 · CA
Impact of smoking and its cessation on systemic and airway immune activation$827,665
R01 · FY2016 · DA
Molecular and Imaging Biomarkers for Early Lung Cancer Detection in the Setting of Indeterminate Pulmonary Nodules$676,510
R01 · FY2016 · CA · contact PI
Integrative Omics to Discover Molecular Determinants of COPD$663,066
R01 · FY2016 · HL
The Boston University-UCLA Lung Cancer Biomarker Development Lab$565,669
U01 · FY2016 · CA · contact PI
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer$812,527
U01 · FY2015 · CA
Integrative Omics to Discover Molecular Determinants of COPD$673,120
R01 · FY2015 · HL
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$185,509
U01 · FY2015 · CA
Integrative Omics to Discover Molecular Determinants of COPD$666,968
R01 · FY2014 · HL
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$598,984
U01 · FY2014 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$499,578
R01 · FY2014 · CA · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$781,158
U01 · FY2013 · CA
Integrative Omics to Discover Molecular Determinants of COPD$744,400
R01 · FY2013 · HL
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$593,827
U01 · FY2013 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$496,897
R01 · FY2013 · CA · contact PI
Molecular biomarkers of airway and lung linking COPD and lung cancer$99,999
R01 · FY2013 · CA · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$783,499
U01 · FY2012 · CA
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$647,222
U01 · FY2012 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$535,797
R01 · FY2012 · CA · contact PI
Validation of a Genomic Biomarker of Response to Environmental Tobacco Smoke$487,236
R01 · FY2012 · ES · contact PI
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$692,695
R01 · FY2011 · HL · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$662,594
U01 · FY2011 · CA
Molecular biomarkers of airway and lung linking COPD and Lung Cancer$562,559
R01 · FY2011 · CA · contact PI
Validation of a Genomic Biomarker of Response to Environmental Tobacco Smoke$521,116
R01 · FY2011 · ES · contact PI
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer$299,488
R01 · FY2011 · CA · contact PI
Lung Genomics Research Consortium$3,759,656
RC2 · FY2010 · HL
Lung Genomics Research Consortium$1,654,805
RC2 · FY2010 · HL
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$725,083
U01 · FY2010 · CA
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$703,846
R01 · FY2010 · HL · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$600,096
U01 · FY2010 · ES · contact PI
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer$308,750
R01 · FY2010 · CA · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$134,727
U01 · FY2010 · ES · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$1,000
U01 · FY2010 · ES · contact PI
Lung Genomics Research Consortium$5,987,215
RC2 · FY2009 · HL
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$737,684
R01 · FY2009 · HL · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$573,459
U01 · FY2009 · ES · contact PI
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer$308,750
R01 · FY2009 · CA · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$302,915
U01 · FY2009 · ES · contact PI
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD$760,175
R01 · FY2008 · HL · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$604,336
U01 · FY2008 · ES · contact PI
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer$308,750
R01 · FY2008 · CA · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$78,126
U01 · FY2008 · ES · contact PI
A non-invasive gene-expression biomarker of airway response to tobacco exposure$646,408
U01 · FY2007 · ES · contact PI
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer$308,750
R01 · FY2007 · CA · contact PI
The Airway Transcriptome as a Biomarker for Lung Cancer$135,626
R21 · FY2006 · CA · contact PI
The Airway Transcriptome as a Biomarker for Lung Cancer$138,890
R21 · FY2005 · CA